The latest research from Fore Pharma, Europe Wet Age-Related Macular Degeneration Market and Competitive Landscape – 2020, provides comprehensive insights into Wet Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Wet Age-Related Macular Degeneration market size and drug sales. It also provides insights into Wet Age-Related Macular Degeneration epidemiology and late stage pipeline.
This research covers the following – Wet Age-Related Macular Degeneration treatment options, Wet Age-Related Macular Degeneration late stage clinical trials pipeline, Wet Age-Related Macular Degeneration prevalence by countries, Wet Age-Related Macular Degeneration market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).
Research Scope:
– Countries: Germany, France, Italy, Spain, UK, Europe
– Wet Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for Wet Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Wet Age-Related Macular Degeneration epidemiology: Find out number of patients diagnosed (prevalence) with Wet Age-Related Macular Degeneration by countries
– Wet Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Wet Age-Related Macular Degeneration by countries, including trade name, molecule name, and company
– Wet Age-Related Macular Degeneration drugs sales: Find out the sales value for Wet Age-Related Macular Degeneration drugs by countries
– Wet Age-Related Macular Degeneration market valuations: Find out the market size for Wet Age-Related Macular Degeneration drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Wet Age-Related Macular Degeneration drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Wet Age-Related Macular Degeneration drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Wet Age-Related Macular Degeneration market
– Develop in-depth knowledge of competition and markets
– Analyze Wet Age-Related Macular Degeneration drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Wet Age-Related Macular Degeneration market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Wet Age-Related Macular Degeneration Treatment Options
2. Wet Age-Related Macular Degeneration Pipeline Insights
2.1. Wet Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Wet Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Wet Age-Related Macular Degeneration Phase 1 Clinical Trials
3. Wet Age-Related Macular Degeneration Epidemiology Analysis by Countries
4. Germany Wet Age-Related Macular Degeneration Market Insights
4.1. Marketed Drugs for Wet Age-Related Macular Degeneration in Germany
4.2. Germany Wet Age-Related Macular Degeneration Market Size & Forecast
4.3. Germany Wet Age-Related Macular Degeneration Drugs Sales Forecast
4.4. Germany Wet Age-Related Macular Degeneration Market Share Analysis
5. France Wet Age-Related Macular Degeneration Market Insights
5.1. Marketed Drugs for Wet Age-Related Macular Degeneration in France
5.2. France Wet Age-Related Macular Degeneration Market Size & Forecast
5.3. France Wet Age-Related Macular Degeneration Product Sales Forecast
5.4. France Wet Age-Related Macular Degeneration Market Share Analysis
6. Italy Wet Age-Related Macular Degeneration Market Insights
6.1. Marketed Drugs for Wet Age-Related Macular Degeneration in Italy
6.2. Italy Wet Age-Related Macular Degeneration Market Size & Forecast
6.3. Italy Wet Age-Related Macular Degeneration Product Sales Forecast
6.4. Italy Wet Age-Related Macular Degeneration Market Share Analysis
7. Spain Wet Age-Related Macular Degeneration Market Insights
7.1. Marketed Drugs for Wet Age-Related Macular Degeneration in Spain
7.2. Spain Wet Age-Related Macular Degeneration Market Size & Forecast
7.3. Spain Wet Age-Related Macular Degeneration Product Sales Forecast
7.4. Spain Wet Age-Related Macular Degeneration Market Share Analysis
8. UK Wet Age-Related Macular Degeneration Market Insights
8.1. Marketed Drugs for Wet Age-Related Macular Degeneration in UK
8.2. UK Wet Age-Related Macular Degeneration Market Size & Forecast
8.3. UK Wet Age-Related Macular Degeneration Product Sales Forecast
8.4. UK Wet Age-Related Macular Degeneration Market Share Analysis
9. Europe Wet Age-Related Macular Degeneration Market Insights
9.1. Europe Wet Age-Related Macular Degeneration Market Size & Forecast
9.2. Europe Wet Age-Related Macular Degeneration Product Sales Forecast
9.3. Europe Wet Age-Related Macular Degeneration Market Share Analysis
10. Research Methodology
List of Tables
1: Wet Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2020
2: Wet Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2020
3: Wet Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2020
4: Wet Age-Related Macular Degeneration Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Wet Age-Related Macular Degeneration in Germany, 2019
6: Germany Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
7: Germany Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
8: Germany Wet Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Wet Age-Related Macular Degeneration in France, 2019
10: France Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
11: France Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
12: France Wet Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Wet Age-Related Macular Degeneration in Italy, 2019
14: Italy Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
15: Italy Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
16: Italy Wet Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Wet Age-Related Macular Degeneration in Spain, 2019
18: Spain Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
19: Spain Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
20: Spain Wet Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Wet Age-Related Macular Degeneration in UK, 2019
22: UK Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
23: UK Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
24: UK Wet Age-Related Macular Degeneration Market Events and Trends, 2016 – 2025
25: Europe Wet Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 – 2025
26: Europe Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
List of Figures
1: Wet Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2020
2: Wet Age-Related Macular Degeneration Prevalence by Countries, 2016 – 2025
3: Germany Wet Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
4: Germany Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
5: Germany Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
6: Germany Wet Age-Related Macular Degeneration Market – Future Market Share (%), 2025
7: France Wet Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
8: France Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
9: France Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
10: France Wet Age-Related Macular Degeneration Market – Future Market Share (%), 2025
11: Italy Wet Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
12: Italy Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
13: Italy Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
14: Italy Wet Age-Related Macular Degeneration Market – Future Market Share (%), 2025
15: Spain Wet Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
16: Spain Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
17: Spain Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
18: Spain Wet Age-Related Macular Degeneration Market – Future Market Share (%), 2025
19: UK Wet Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
20: UK Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
21: UK Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
22: UK Wet Age-Related Macular Degeneration Market – Future Market Share (%), 2025
23: Europe Wet Age-Related Macular Degeneration Market Size ($mn), 2016 – 2025
24: Europe Wet Age-Related Macular Degeneration Product Sales ($mn), 2016 – 2025
25: Europe Wet Age-Related Macular Degeneration Market Share by Drugs (%), 2019
26: Europe Wet Age-Related Macular Degeneration Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.